Stuart Paynter1, Robert S Ware, Marilla G Lucero, Veronica Tallo, Hannah Nohynek, Philip Weinstein, Gail Williams, Peter D Sly, Eric A F Simões. 1. From the *School of Population Health; †Queensland Children's Medical Research Institute, University of Queensland, Brisbane, Australia; ‡Research Institute of Tropical Medicine, Manila, the Philippines; §Department of Vaccines and Immune Protection, National Institute for Health and Welfare, Helsinki, Finland; ¶Barbara Hardy Institute, University of South Australia, Adelaide, Australia; ‖University of Colorado Denver, School of Medicine; Center for Global Health, Colorado School of Public Health; and **Children's Hospital Colorado, Aurora, CO.
Abstract
BACKGROUND: Longitudinal information examining the effect of poor infant growth on respiratory syncytial virus (RSV) severity is limited. Children hospitalized with RSV lower respiratory infection represent those at the severe end of the disease spectrum. METHODS: We followed up a cohort of 12,191 infants enrolled in a previous pneumococcal vaccine trial in Bohol, Philippines. Exposure measures were weight for age z-score at the first vaccination visit (median age 1.8 months) as well as the growth (the difference in weight for age z-score) between the first and third vaccination visits. The outcome was hospitalization with RSV lower respiratory infection. RESULTS: Children with a weight for age z-score ≤ -2 at their first vaccination visit had the highest rate of hospitalization with RSV lower respiratory infection, but this association was only evident in children whose mothers had >10 years of education (hazard ratio: 3.38; 95% confidence interval: 1.63-6.98). Children who had lower than median growth between their first and third vaccinations had a higher rate of RSV-associated hospitalization than those with growth above the median (hazard ratio: 1.34; 95% confidence interval: 1.02-1.76). CONCLUSIONS: Poor infant growth increases the risk for severe RSV infection leading to hospitalization.
BACKGROUND: Longitudinal information examining the effect of poor infant growth on respiratory syncytial virus (RSV) severity is limited. Children hospitalized with RSV lower respiratory infection represent those at the severe end of the disease spectrum. METHODS: We followed up a cohort of 12,191 infants enrolled in a previous pneumococcal vaccine trial in Bohol, Philippines. Exposure measures were weight for age z-score at the first vaccination visit (median age 1.8 months) as well as the growth (the difference in weight for age z-score) between the first and third vaccination visits. The outcome was hospitalization with RSV lower respiratory infection. RESULTS:Children with a weight for age z-score ≤ -2 at their first vaccination visit had the highest rate of hospitalization with RSV lower respiratory infection, but this association was only evident in children whose mothers had >10 years of education (hazard ratio: 3.38; 95% confidence interval: 1.63-6.98). Children who had lower than median growth between their first and third vaccinations had a higher rate of RSV-associated hospitalization than those with growth above the median (hazard ratio: 1.34; 95% confidence interval: 1.02-1.76). CONCLUSIONS: Poor infant growth increases the risk for severe RSV infection leading to hospitalization.
Authors: Sweta M Patel; Lisa Spees; Marek Smieja; Kathy Luinstra; Andrew P Steenhoff; Kristen A Feemster; Tonya Arscott-Mills; Sefelani Boiditswe; Mohamed Z Patel; Samir S Shah; Coleen K Cunningham; Matthew S Kelly Journal: Pediatr Infect Dis J Date: 2019-05 Impact factor: 2.129
Authors: Melody Hermel; Megan Sweeney; Yu-Ming Ni; Robert Bonakdar; Douglas Triffon; Christopher Suhar; Sandeep Mehta; Sarah Dalhoumi; James Gray Journal: J Evid Based Integr Med Date: 2021 Jan-Dec
Authors: Ting Shi; Evelyn Balsells; Elizabeth Wastnedge; Rosalyn Singleton; Zeba A Rasmussen; Heather J Zar; Barbara A Rath; Shabir A Madhi; Stuart Campbell; Linda Cheyenne Vaccari; Lisa R Bulkow; Elizabeth D Thomas; Whitney Barnett; Christian Hoppe; Harry Campbell; Harish Nair Journal: J Glob Health Date: 2015-12 Impact factor: 4.413
Authors: Stuart Paynter; Laith Yakob; Eric A F Simões; Marilla G Lucero; Veronica Tallo; Hanna Nohynek; Robert S Ware; Philip Weinstein; Gail Williams; Peter D Sly Journal: PLoS One Date: 2014-02-27 Impact factor: 3.240